SAFETY AND EFFICACY OF TRANSCATHETER AORTIC VALVE REPLACEMENT FOR NATIVE PURE AORTIC VALVE REGURGITATION: SINGLE-CENTER EXPERIENCE
Anno:
2024
Background: TAVR has become the standard of care for high-risk patients with aortic stenosis. Considering unique procedural challenges posed by native pure aortic regurgitation (NPAR), our aim was to evaluate early and mid-term results of off-label treatment with new generation devices. Materials and Methods: We retrospectively enrolled 61 consecutive…